NCT00545324已完成4 期
A 12 Week Multicenter, Open-Label, Randomized, Observational Study Comparing Singulair® 10 Mg As Controller Monotherapy In Adults With Mild Asthma "To Low Dose" Inhaled Corticosteroid Treatment
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 399
- 主要终点
- Canadian asthma guidelines criteria
研究概览
简要总结
In adult patients with mild persistent asthma, singulair® 10 mg will be at least as effective as low dose Inhaled Corticosteroids (ICS) in improving asthma symptom control or satisfaction over a 6 week comparison period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •First time diagnosis of mild asthma symptoms which requires an antiinflammatory controller medication
- •Patients not controlled with short acting beta2 agonist (sab) therapy (requiring more than one treatment per week but less than 7 per week)
- •Patients dissatisfied with low dose ics therapy, or patients reluctant to take ics therapy, or patients insufficiently controlled due to non-compliance with low dose ics therapy through out the preceding 6 weeks
- •Patient's forced expiratory volume in one second (fev1) is < 80% of predicted value
排除标准
- •Patient on combination therapy
- •Patient on long acting beta2 agonists
- •Patient on using moderate to high doses of ICS. (ICS >250 µ g/day flovent® or equivalent per day)
结局指标
主要结局
Canadian asthma guidelines criteria
次要结局
- Asthma control questionnaire
研究者
相似试验
已完成
2 期
Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated EosinophilsAsthmaNCT01366521GlaxoSmithKline70
已完成
3 期
Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)AsthmaNCT00337675Organon and Co1,771
已完成
不适用
IL-13 Blockade and Airway Autoimmunity in AsthmaAirway Auto Immunity in AsthmaNCT05564078McMaster University30
已完成
4 期
Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose CombinationsAsthmaNCT01449123Mundipharma AB97
已完成
不适用
Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta AgonistModerate AsthmaNCT05757908Koneksa Health29
